“ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY”. (2023) Student’s Journal of Health Research Africa, 4(12), p. 5. doi:10.51168/sjhrafrica.v4i12.865.